PAKISTANI drug manufacturers are not allowed third-party contracts -a f acility which gives Bangladesh and India a clear edge over Pakistan. It is time the current legislation, which restricts contact manuf acturing of medicines, helped localmanufacturers reach ef ficient scales and become more competitive.
With third-party contract manufacturing, Pakistan can speed up industrialisation since many companies will then offer to produce drug on behalf of established brands.
This will also open more employment opportunities. Third-party manuf acturing will bring in foreign investment as international drug manuf acturers will prefer to outsource medicine production to Pakistani firms to offset their own high production costs.
There is an urgent need for reforms in the existing regulatory framework to unlock the potential of `scale` within the local pharmaceutical manuf acturing sector to produce essential drugs locally and also give our manufacturers access to global markets.
Fiza Feroz Karachimanufacturers reach ef ficient scales and become more competitive.
With third-party contract manufacturing, Pakistan can speed up industrialisation since many companies will then offer to produce drug on behalf of established brands.
This will also open more employment opportunities. Third-party manuf acturing will bring in foreign investment as international drug manuf acturers will prefer to outsource medicine production to Pakistani firms to offset their own high production costs.
There is an urgent need for reforms in the existing regulatory framework to unlock the potential of `scale` within the local pharmaceutical manuf acturing sector to produce essential drugs locally and also give our manufacturers access to global markets.
